XML 89 R56.htm IDEA: XBRL DOCUMENT v3.24.1
Shareholders' Equity (Deficit) (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Jul. 16, 2021
$ / shares
shares
Jun. 01, 2021
$ / shares
shares
Mar. 18, 2021
$ / shares
shares
Mar. 18, 2021
$ / shares
shares
Dec. 31, 2020
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
shares
Dec. 31, 2021
USD ($)
shares
Dec. 26, 2023
USD ($)
$ / shares
shares
Dec. 17, 2021
shares
Jun. 01, 2021
₪ / shares
shares
Shareholders' Equity [Line Items]                      
Aggregate of ordinary shares         756,333 655,601 1,240,204        
Ordinary shares   8,435,375 24,800,000 1   1,877,196          
Ordinary shares capital   15,000,000 310,000,000 310,000,000   22,382         15,000,000
Warrants exercise price (in Dollars per share) | $ / shares $ 5.5                    
Shareholders approved | (per share)   $ 2.94                 ₪ 0.125
Authorized share capital     310,000,000 310,000,000              
Reverse split   reverse split at a ratio of 2.94 to 1                  
Sold ordinary shares 2,909,091                    
Tradable warrants 3,345,455                    
Additional offering direct costs (in Dollars) | $           $ 1,543          
Gross proceeds (in Dollars) | $           $ 16,033          
Fair value warrants           436,364          
Granted to underwriters (in Dollars) | $           $ 589          
Tradable warrants to purchase           145,455          
Percentage of exercise price           125.00%          
Percentage of exercise of tradable warrants           7.00%          
Fair value of the financial liability (in Dollars) | $           $ 310          
Non-cash expenses (in Dollars) | $           1,163          
Non-direct expenses (in Dollars) | $           722          
Cash expenses (in Dollars) | $           123          
Profit and loss (in Dollars) | $           $ 546          
Options exercise shares           133,329 7,030 24,631      
Authorized share capital                   100,000,000  
Stock Issued During Period, Shares, Other           17,566          
Purchase price of per share (in Dollars per share) | $ / shares                 $ 1.28    
Pre funded warrant, per share (in Dollars per share) | $ / shares                 $ 0.001    
Underwriting discounts (in Dollars) | $           $ 3,424          
Offering cost (in Dollars) | $           $ 454     $ 3,424    
Percentage of agreement warrants           7.00%          
Price per share (in Dollars per share) | $ / shares           $ 1.6          
Issuance costs (in Dollars) | $           $ 131   $ 131      
Common Stock [Member]                      
Shareholders' Equity [Line Items]                      
Ordinary shares capital                 1,375,000    
Options exercise shares           37,972          
Stock Issued During Period, Shares, Other           17,566          
Purchase price of per share (in Dollars per share) | $ / shares                 $ 1.28    
Maximum [Member]                      
Shareholders' Equity [Line Items]                      
Shareholders approved | $ / shares     $ 12.5 $ 12.5              
Minimum [Member]                      
Shareholders' Equity [Line Items]                      
Ordinary shares capital     1 1              
Pre-Funded Warrants [Member]                      
Shareholders' Equity [Line Items]                      
Ordinary shares capital           1,656,250     1,375,000    
Shareholders approved | $ / shares           $ 0.01          
Purchase price of per share (in Dollars per share) | $ / shares                 $ 1.28    
Warrant purchase [Member]                      
Shareholders' Equity [Line Items]                      
Ordinary shares capital           212,188     1,656,250    
Purchase price of per share (in Dollars per share) | $ / shares                 $ 1.28    
Warrant purchase [Member] | Common Stock [Member]                      
Shareholders' Equity [Line Items]                      
Ordinary shares capital                 3,031,250    
IPO [Member]                      
Shareholders' Equity [Line Items]                      
Aggregate of ordinary shares           27,566          
Ordinary shares capital         169,019 2,113,905          
Proceeds received (in Dollars) | $           $ 14,490          
Granted to underwriters (in Dollars) | $           264          
Non-direct expenses (in Dollars) | $           3,551          
Profit and loss (in Dollars) | $           $ 3,032          
Over-Allotment Option [Member]                      
Shareholders' Equity [Line Items]                      
Tradable warrants 436,364                    
Restricted Stock Units [Member]                      
Shareholders' Equity [Line Items]                      
Aggregate of ordinary shares           1,226,448          
Common Stock [Member]                      
Shareholders' Equity [Line Items]                      
Ordinary shares capital           212,188          
Warrants exercise price (in Dollars per share) | $ / shares         $ 5.5            
Shareholders approved | $ / shares     $ 12.5 $ 12.5              
Investor [Member]                      
Shareholders' Equity [Line Items]                      
Non tradable warrants           1,149,582          
Brokers [Member]                      
Shareholders' Equity [Line Items]                      
Non tradable warrants           16,587